Peer-reviewedCC BYFrontiers in immunology
Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
- 1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University , , ,
- 2State Key Laboratory of Biotherapy and Cancer Center, Sichuan University and Collaborative Innovation Center, West China Hospital , , ,
Related
- Combined Image-Based Profiling and Biochemical Analysis of GCaMP Overexpression Effects on Mammalian Cells
- Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
- Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach
- Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
- H3K18 lactylation promotes Treg/Th17 imbalance via PTPRM-STAT3 axis in hepatocellular carcinoma
BibTeX
@article{xu2026gefitinibbased,
title = {{Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report}},
author = {Qin Xu and Xiaofen Li and Rui Zhu and Zirui Wang and Nuerye Tuerhonga and Chengjian Zhao and Yu Yang},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655545},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
AU - Qin Xu
AU - Xiaofen Li
AU - Rui Zhu
AU - Zirui Wang
AU - Nuerye Tuerhonga
AU - Chengjian Zhao
AU - Yu Yang
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13655545
SN - 1664-3224
ER -